10.08.10
Moderately to highly stressed women experienced fewer cold/flu symptoms and higher energy levels while taking Wellmune WGP from Biothera, according to research presented at the 51st Annual Meeting of the American College of Nutrition.
Seventy-seven healthy women (age 38 + 12 years) pre-screened for moderate levels of psychological stress were given either a placebo or 250 mg of Wellmune WGP daily for 12 weeks. Only 10% of the Wellmune group reported upper respiratory tract infection symptoms (sore throat, stuffy or runny nose, and cough) compared with 29% for the control group.
The study used the Profile of Mood States (POMS) psychological survey to assess changes in mental/physical energy levels (vigor) and overall well-being (Global Mood State). Vigor improved 41% in women taking Wellmune WGP compared with 7% in the control group. Similarly, the Global Mood State of women taking Wellmune improved 29% compared with 16% in the placebo group. For further information: www.biothera.com
Seventy-seven healthy women (age 38 + 12 years) pre-screened for moderate levels of psychological stress were given either a placebo or 250 mg of Wellmune WGP daily for 12 weeks. Only 10% of the Wellmune group reported upper respiratory tract infection symptoms (sore throat, stuffy or runny nose, and cough) compared with 29% for the control group.
The study used the Profile of Mood States (POMS) psychological survey to assess changes in mental/physical energy levels (vigor) and overall well-being (Global Mood State). Vigor improved 41% in women taking Wellmune WGP compared with 7% in the control group. Similarly, the Global Mood State of women taking Wellmune improved 29% compared with 16% in the placebo group. For further information: www.biothera.com